VOR's logo.
Ticker Symbol: VOR

Vor Biopharma Inc

$17.30 - 02-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001817229

Company Profile

Vor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of targeted therapies. By removing biologically redundant proteins from eHSCs, we design these cells and their progeny to be treatment-resistant to complementary targeted therapies, thereby enabling these therapies to selectively destroy cancerous cells while sparing healthy cells.

Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2836
Address: N/A
CEO: N/A
Tags: N/A

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $2.06
Change: $0.11 ( 5.63%)
Days Range: $1.89 - $2.10
Beta: 1.03
52wk. High: $7.57
52wk. Low: $1.89
Ytd. Change -64.97%
50 Day Moving Average: $2.25
200 Day Moving Average: $3.45
Shares Outstanding: 67538680

Valuation

Market Cap: 13.9B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A